Stroke News

Healio and Cardiology Today have compiled a list of the top headlines in cardiology from February 2023.

A popular artificial sweetener, erythritol, was linked to worsened risks for heart attack and stroke, according to new research published in Nature Medicine.

Researchers in China have identified specific gut microbiome bacteria that may influence risk for several subtypes of ischemic stroke, according to research published in the European Journal of Preventive Cardiology.

Long-term exposure to air pollutants may be associated with increased readmissions after ischemic stroke, according to data published in Stroke.

Cerebral amyloid angiopathy was associated with a higher risk for isolated nontraumatic subdural hemorrhage in two large, independent cohorts, according to research presented at International Stroke Conference.

Researchers observed no difference in 3-month functional outcomes or mortality among patients with acute ischemic stroke who underwent early BP-lowering therapy compared with a delayed strategy, a speaker reported.

Tenecteplase was noninferior to alteplase for acute ischemic stroke when given within 4.5 hours of symptom onset in patients not eligible for endovascular thrombectomy, according to research presented at International Stroke Conference.

Administration of Toll-receptor 4 antagonist ApTOLL within 6 hours of acute ischemic stroke, along with endovascular treatment, was linked to reduced mortality and disability at 90 days compared with placebo.

Lower target systolic BP after successful endovascular therapy demonstrated a signal of harm and only a marginal probability of benefit toward infarct volume and disability, a speaker reported.

People with autism are at an increased risk for cardiometabolic diseases, and the risks are even higher among children with autism, according to findings from a systematic review and meta-analysis published in JAMA Pediatrics.